P3 Health Partners (PIII)
(Delayed Data from NSDQ)
$0.38 USD
0.00 (0.48%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $0.37 -0.01 (-2.12%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth B Momentum C VGM
Income Statements
Fiscal Year end for P3 Health Partners Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,266 | 1,049 | 637 | 0 | 145 |
Cost Of Goods | 1,235 | 1,057 | 659 | 0 | 141 |
Gross Profit | 32 | -8 | -22 | 0 | 4 |
Selling & Adminstrative & Depr. & Amort Expenses | 200 | 1,553 | 166 | 0 | 44 |
Income After Depreciation & Amortization | -168 | -1,561 | -188 | 0 | -40 |
Non-Operating Income | 0 | 13 | -5 | 0 | 0 |
Interest Expense | 16 | 11 | 11 | 0 | 3 |
Pretax Income | -184 | -1,560 | -204 | 0 | -42 |
Income Taxes | 3 | 2 | 0 | 0 | 0 |
Minority Interest | -129 | -1,291 | -48 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -186 | -1,562 | -204 | 0 | -42 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -58 | -270 | -156 | 0 | -42 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -81 | -158 | -177 | 0 | -39 |
Depreciation & Amortization (Cash Flow) | 87 | 1,403 | 11 | 0 | 0 |
Income After Depreciation & Amortization | -168 | -1,561 | -188 | 0 | -40 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 294.59 | 41.60 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.63 | 4.64 | NA | NA | NA |
Diluted Net EPS (GAAP) | -0.63 | -6.50 | -3.76 | NA | NA |
Fiscal Year end for P3 Health Partners Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 379.16 | 388.49 | 346.86 | 288.35 | 329.09 |
Cost Of Goods | 365.17 | 382.06 | 367.68 | 279.22 | 302.27 |
Gross Profit | 13.99 | 6.43 | -20.82 | 9.13 | 26.82 |
SG&A, R&D, and Dept/Amort Expenses | 45.32 | 50.26 | 43.44 | 42.95 | 47.85 |
Income After SG&A, R&D, and Dept/Amort Expenses | -31.33 | -43.83 | -64.26 | -33.82 | -21.03 |
Non-Operating Income | 8.96 | 0.55 | 0.97 | 0.95 | -2.47 |
Interest Expense | 5.44 | 4.26 | 4.05 | 4.00 | 3.85 |
Pretax Income | -27.81 | -47.53 | -67.34 | -36.88 | -27.36 |
Income Taxes | 0.97 | 2.07 | 1.77 | 0.41 | 0.23 |
Minority Interest | -16.75 | -30.91 | -43.65 | -23.99 | -17.77 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -28.77 | -49.61 | -69.11 | -37.29 | -27.58 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -12.02 | -18.70 | -25.46 | -13.30 | -9.82 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 141.08 | 118.89 | 115.30 | 312.68 | 107.45 |
Diluted EPS Before Non-Recurring Items | -0.15 | -0.16 | -0.22 | -0.12 | -0.09 |
Diluted Net EPS (GAAP) | -0.15 | -0.16 | -0.20 | -0.12 | -0.09 |